Novo Nordisk's new top executive will need to help the company close the gap with Eli Lilly, fend off emerging rivals and ...

Novo Nordisk A/S NVO shares lost 2.7% on Friday after a surprising announcement regarding changes to its executive leadership ...

Asian shares are lower after Moody's Ratings downgraded the sovereign credit rating for the United States. U.S. futures and ...

Most major stock indexes across the globe moved upwards on a weekly basis, taking support from the uptick in US equities.

On Wall Street, Charter Communications rose 1.8% after it said it agreed to merge with Cox Communications in a deal that ...

In an abrupt and surprising twist, the CEO of Ozempic-maker Novo Nordisk has been ousted from his position as the head of the ...

Novo Nordisk on Wednesday managed the unusual feat of seeing its stock price rise after reducing its earnings outlook. But that's reflective of the tough times the Danish maker of Ozempic and ...

Analysts from BMO Capital have downgraded Novo Nordisk’s stock from ’Outperform’ to ’Market Perform,’ citing competitive pressures from Eli Lilly (NYSE:LLY) and concerns over Novo ...

Despite the downgrade, Novo Nordisk’s shares rose 4.4% at the European market open. However, the stock remains down 26% year-to-date, compared with a flat performance by its main US rival ...

U.S.-listed shares of Novo Nordisk (NVO) are jumping in premarket ... UBS analysts Wednesday stuck with their "buy" rating on the stock, saying they expect a relief rally with the guidance cut ...